Vemurafenib Withdrawn Phase 1 Trials for Recurrent Melanoma / Stage IV Melanoma / Tumors Metastatic to Brain Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02145910Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases